Global Influenza Vaccine Market Growth 2020-2025


According to this study, over the next five years the Influenza Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccine market by type, application, key manufacturers and key regions and countries.

This study considers the Influenza Vaccine value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    Whole Virus Vaccines
    Split Virus Vaccines
    Subunit Vaccines
    Live Attenuated Virus Vaccines

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    For Children (6 months to 3 years)
    For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    CSL
    GSK
    Mylan
    AstraZeneca
    Sanofi Pasteur
    Pfizer
    Johnson & Johnson
    ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global Influenza Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of Influenza Vaccine market by identifying its various subsegments.
    Focuses on the key global Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Influenza Vaccine Consumption 2015-2025
        2.1.2 Influenza Vaccine Consumption CAGR by Region
    2.2 Influenza Vaccine Segment by Type
        2.2.1 Whole Virus Vaccines
        2.2.2 Split Virus Vaccines
        2.2.3 Subunit Vaccines
        2.2.4 Live Attenuated Virus Vaccines
    2.3 Influenza Vaccine Consumption by Type
        2.3.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
        2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2015-2020)
        2.3.3 Global Influenza Vaccine Sale Price by Type (2015-2020)
    2.4 Influenza Vaccine Segment by Application
        2.4.1 For Children (6 months to 3 years)
        2.4.2 For Adults and Children over 3 years
    2.5 Influenza Vaccine Consumption by Application
        2.5.1 Global Influenza Vaccine Consumption Market Share by Type (2015-2020)
        2.5.2 Global Influenza Vaccine Value and Market Share by Type (2015-2020)
        2.5.3 Global Influenza Vaccine Sale Price by Type (2015-2020)

3 Global Influenza Vaccine by Company
    3.1 Global Influenza Vaccine Sales Market Share by Company
        3.1.1 Global Influenza Vaccine Sales by Company (2018-2020)
        3.1.2 Global Influenza Vaccine Sales Market Share by Company (2018-2020)
    3.2 Global Influenza Vaccine Revenue Market Share by Company
        3.2.1 Global Influenza Vaccine Revenue by Company (2018-2020)
        3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2018-2020)
    3.3 Global Influenza Vaccine Sale Price by Company
    3.4 Global Influenza Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global Influenza Vaccine Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players Influenza Vaccine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 Influenza Vaccine by Regions
    4.1 Influenza Vaccine by Regions
    4.2 Americas Influenza Vaccine Consumption Growth
    4.3 APAC Influenza Vaccine Consumption Growth
    4.4 Europe Influenza Vaccine Consumption Growth
    4.5 Middle East & Africa Influenza Vaccine Consumption Growth

5 Americas
    5.1 Americas Influenza Vaccine Consumption by Countries
        5.1.1 Americas Influenza Vaccine Consumption by Countries (2015-2020)
        5.1.2 Americas Influenza Vaccine Value by Countries (2015-2020)
    5.2 Americas Influenza Vaccine Consumption by Type
    5.3 Americas Influenza Vaccine Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC Influenza Vaccine Consumption by Regions
        6.1.1 APAC Influenza Vaccine Consumption by Regions (2015-2020)
        6.1.2 APAC Influenza Vaccine Value by Regions (2015-2020)
    6.2 APAC Influenza Vaccine Consumption by Type
    6.3 APAC Influenza Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe Influenza Vaccine by Countries
        7.1.1 Europe Influenza Vaccine Consumption by Countries (2015-2020)
        7.1.2 Europe Influenza Vaccine Value by Countries (2015-2020)
    7.2 Europe Influenza Vaccine Consumption by Type
    7.3 Europe Influenza Vaccine Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Spain
    7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa Influenza Vaccine by Countries
        8.1.1 Middle East & Africa Influenza Vaccine Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa Influenza Vaccine Value by Countries (2015-2020)
    8.2 Middle East & Africa Influenza Vaccine Consumption by Type
    8.3 Middle East & Africa Influenza Vaccine Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 Influenza Vaccine Distributors
    10.3 Influenza Vaccine Customer

11 Global Influenza Vaccine Market Forecast
    11.1 Global Influenza Vaccine Consumption Forecast (2021-2025)
    11.2 Global Influenza Vaccine Forecast by Regions
        11.2.1 Global Influenza Vaccine Forecast by Regions (2021-2025)
        11.2.2 Global Influenza Vaccine Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast by Countries
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
        11.5.6 Spain Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global Influenza Vaccine Forecast by Type
    11.8 Global Influenza Vaccine Forecast by Application

12 Key Players Analysis
    12.1 CSL
        12.1.1 Company Information
        12.1.2 Influenza Vaccine Product Offered
        12.1.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 CSL Latest Developments
    12.2 GSK
        12.2.1 Company Information
        12.2.2 Influenza Vaccine Product Offered
        12.2.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 GSK Latest Developments
    12.3 Mylan
        12.3.1 Company Information
        12.3.2 Influenza Vaccine Product Offered
        12.3.3 Mylan Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 Mylan Latest Developments
    12.4 AstraZeneca
        12.4.1 Company Information
        12.4.2 Influenza Vaccine Product Offered
        12.4.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 AstraZeneca Latest Developments
    12.5 Sanofi Pasteur
        12.5.1 Company Information
        12.5.2 Influenza Vaccine Product Offered
        12.5.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 Sanofi Pasteur Latest Developments
    12.6 Pfizer
        12.6.1 Company Information
        12.6.2 Influenza Vaccine Product Offered
        12.6.3 Pfizer Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 Pfizer Latest Developments
    12.7 Johnson & Johnson
        12.7.1 Company Information
        12.7.2 Influenza Vaccine Product Offered
        12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 Johnson & Johnson Latest Developments
    ...

13 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Influenza Vaccine Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Whole Virus Vaccines Table 5. Major Players of Split Virus Vaccines Table 6. Major Players of Subunit Vaccines Table 7. Major Players of Live Attenuated Virus Vaccines Table 8. Global Consumption Sales by Type (2015-2020) Table 9. Global Influenza Vaccine Consumption Market Share by Type (2015-2020) Table 10. Global Influenza Vaccine Revenue by Type (2015-2020) ($ million) Table 11. Global Influenza Vaccine Value Market Share by Type (2015-2020) ($ Millions) Table 12. Global Influenza Vaccine Sale Price by Type (2015-2020) Table 13. Global Consumption Sales by Application (2015-2020) Table 14. Global Influenza Vaccine Consumption Market Share by Application (2015-2020) Table 15. Global Influenza Vaccine Value by Application (2015-2020) Table 16. Global Influenza Vaccine Value Market Share by Application (2015-2020) Table 17. Global Influenza Vaccine Sale Price by Application (2015-2020) Table 18. Global Influenza Vaccine Sales by Company (2017-2019) (K Doses) Table 19. Global Influenza Vaccine Sales Market Share by Company (2017-2019) Table 20. Global Influenza Vaccine Revenue by Company (2017-2019) ($ Millions) Table 21. Global Influenza Vaccine Revenue Market Share by Company (2017-2019) Table 22. Global Influenza Vaccine Sale Price by Company (2017-2019) Table 23. Global Influenza Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers Table 24. Players Influenza Vaccine Products Offered Table 25. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 26. Global Influenza Vaccine Consumption by Regions 2015-2020 (K Doses) Table 27. Global Influenza Vaccine Consumption Market Share by Regions 2015-2020 Table 28. Global Influenza Vaccine Value by Regions 2015-2020 ($ Millions) Table 29. Global Influenza Vaccine Value Market Share by Regions 2015-2020 Table 30. Americas Influenza Vaccine Consumption by Countries (2015-2020) (K Doses) Table 31. Americas Influenza Vaccine Consumption Market Share by Countries (2015-2020) Table 32. Americas Influenza Vaccine Value by Countries (2015-2020) ($ Millions) Table 33. Americas Influenza Vaccine Value Market Share by Countries (2015-2020) Table 34. Americas Influenza Vaccine Consumption by Type (2015-2020) (K Doses) Table 35. Americas Influenza Vaccine Consumption Market Share by Type (2015-2020) Table 36. Americas Influenza Vaccine Consumption by Application (2015-2020) (K Doses) Table 37. Americas Influenza Vaccine Consumption Market Share by Application (2015-2020) Table 38. APAC Influenza Vaccine Consumption by Countries (2015-2020) (K Doses) Table 39. APAC Influenza Vaccine Consumption Market Share by Countries (2015-2020) Table 40. APAC Influenza Vaccine Value by Regions (2015-2020) ($ Millions) Table 41. APAC Influenza Vaccine Value Market Share by Regions (2015-2020) Table 42. APAC Influenza Vaccine Consumption by Type (2015-2020) (K Doses) Table 43. APAC Influenza Vaccine Consumption Market Share by Type (2015-2020) Table 44. APAC Influenza Vaccine Consumption by Application (2015-2020) (K Doses) Table 45. APAC Influenza Vaccine Consumption Market Share by Application (2015-2020) Table 46. Europe Influenza Vaccine Consumption by Countries (2015-2020) (K Doses) Table 47. Europe Influenza Vaccine Consumption Market Share by Countries (2015-2020) Table 48. Europe Influenza Vaccine Value by Countries (2015-2020) ($ Millions) Table 49. Europe Influenza Vaccine Value Market Share by Countries (2015-2020) Table 50. Europe Influenza Vaccine Consumption by Type (2015-2020) (K Doses) Table 51. Europe Influenza Vaccine Consumption Market Share by Type (2015-2020) Table 52. Europe Influenza Vaccine Consumption by Application (2015-2020) (K Doses) Table 53. Europe Influenza Vaccine Consumption Market Share by Application (2015-2020) Table 54. Middle East & Africa Influenza Vaccine Consumption by Countries (2015-2020) (K Doses) Table 55. Middle East & Africa Influenza Vaccine Consumption Market Share by Countries (2015-2020) Table 56. Middle East & Africa Influenza Vaccine Value by Countries (2015-2020) ($ Millions) Table 57. Middle East & Africa Influenza Vaccine Value Market Share by Countries (2015-2020) Table 58. Middle East & Africa Influenza Vaccine Consumption by Type (2015-2020) (K Doses) Table 59. Middle East & Africa Influenza Vaccine Consumption Market Share by Type (2015-2020) Table 60. Middle East & Africa Influenza Vaccine Consumption by Application (2015-2020) (K Doses) Table 61. Middle East & Africa Influenza Vaccine Consumption Market Share by Application (2015-2020) Table 62. Influenza Vaccine Distributors List Table 63. Influenza Vaccine Customer List Table 64. Global Influenza Vaccine Consumption Forecast by Countries (2021-2025) (K Doses) Table 65. Global Influenza Vaccine Consumption Market Forecast by Regions Table 66. Global Influenza Vaccine Value Forecast by Countries (2021-2025) ($ Millions) Table 67. Global Influenza Vaccine Value Market Share Forecast by Regions Table 68. Global Influenza Vaccine Consumption Forecast by Type (2021-2025) (K Doses) Table 69. Global Influenza Vaccine Consumption Market Share Forecast by Type (2021-2025) Table 70. Global Influenza Vaccine Value Forecast by Type (2021-2025) ($ Millions) Table 71. Global Influenza Vaccine Value Market Share Forecast by Type (2021-2025) Table 72. Global Influenza Vaccine Consumption Forecast by Application (2021-2025) (K Doses) Table 73. Global Influenza Vaccine Consumption Market Share Forecast by Application (2021-2025) Table 74. Global Influenza Vaccine Value Forecast by Application (2021-2025) ($ Millions) Table 75. Global Influenza Vaccine Value Market Share Forecast by Application (2021-2025) Table 76. CSL Product Offered Table 77. CSL Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E) Table 78. CSL Main Business Table 79. CSL Latest Developments Table 80. CSL Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 81. GSK Product Offered Table 82. GSK Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E) Table 83. GSK Main Business Table 84. GSK Latest Developments Table 85. GSK Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 86. Mylan Product Offered Table 87. Mylan Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E) Table 88. Mylan Main Business Table 89. Mylan Latest Developments Table 90. Mylan Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 91. AstraZeneca Product Offered Table 92. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E) Table 93. AstraZeneca Main Business Table 94. AstraZeneca Latest Developments Table 95. AstraZeneca Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 96. Sanofi Pasteur Product Offered Table 97. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E) Table 98. Sanofi Pasteur Main Business Table 99. Sanofi Pasteur Latest Developments Table 100. Sanofi Pasteur Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 101. Pfizer Product Offered Table 102. Pfizer Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E) Table 103. Pfizer Main Business Table 104. Pfizer Latest Developments Table 105. Pfizer Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 106. Johnson & Johnson Product Offered Table 107. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. Johnson & Johnson Main Business Table 109. Johnson & Johnson Latest Developments Table 110. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2018-2020E) List of Figures Figure 1. Picture of Influenza Vaccine Figure 2. Influenza Vaccine Report Years Considered Figure 3. Market Research Methodology Figure 4. Global Influenza Vaccine Consumption Growth Rate 2015-2025 (K Doses) Figure 5. Global Influenza Vaccine Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Whole Virus Vaccines Figure 7. Product Picture of Split Virus Vaccines Figure 8. Product Picture of Subunit Vaccines Figure 9. Product Picture of Live Attenuated Virus Vaccines Figure 10. Global Influenza Vaccine Consumption Market Share by Type (2015-2020) Figure 11. Global Influenza Vaccine Value Market Share by Type (2015-2020) Figure 12. Influenza Vaccine Consumed in For Children (6 months to 3 years) Figure 13. Global Influenza Vaccine Market: For Children (6 months to 3 years) (2015-2020) (K Doses) Figure 14. Global Influenza Vaccine Market: For Children (6 months to 3 years) (2015-2020) ($ Millions) Figure 15. Influenza Vaccine Consumed in For Adults and Children over 3 years Figure 16. Global Influenza Vaccine Market: For Adults and Children over 3 years (2015-2020) (K Doses) Figure 17. Global Influenza Vaccine Market: For Adults and Children over 3 years (2015-2020) ($ Millions) Figure 18. Global Influenza Vaccine Consumption Market Share by Application (2015-2020) Figure 19. Global Influenza Vaccine Value Market Share by Application (2015-2020) Figure 20. Global Influenza Vaccine Sales Market Share by Company in 2017 Figure 21. Global Influenza Vaccine Sales Market Share by Company in 2019 Figure 22. Global Influenza Vaccine Revenue Market Share by Company in 2017 Figure 23. Global Influenza Vaccine Revenue Market Share by Company in 2019 Figure 24. Global Influenza Vaccine Sale Price by Company in 2019 Figure 25. Global Influenza Vaccine Consumption Market Share by Regions 2015-2020 Figure 26. Global Influenza Vaccine Value Market Share by Regions 2015-2020 Figure 27. Americas Influenza Vaccine Consumption 2015-2020 (K Doses) Figure 28. Americas Influenza Vaccine Value 2015-2020 ($ Millions) Figure 29. APAC Influenza Vaccine Consumption 2015-2020 (K Doses) Figure 30. APAC Influenza Vaccine Value 2015-2020 ($ Millions) Figure 31. Europe Influenza Vaccine Consumption 2015-2020 (K Doses) Figure 32. Europe Influenza Vaccine Value 2015-2020 ($ Millions) Figure 33. Middle East & Africa Influenza Vaccine Consumption 2015-2020 (K Doses) Figure 34. Middle East & Africa Influenza Vaccine Value 2015-2020 ($ Millions) Figure 35. Americas Influenza Vaccine Consumption Market Share by Countries in 2019 Figure 36. Americas Influenza Vaccine Value Market Share by Countries in 2019 Figure 37. Americas Influenza Vaccine Consumption Market Share by Type in 2019 Figure 38. Americas Influenza Vaccine Consumption Market Share by Application in 2019 Figure 39. United States Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 40. United States Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 41. Canada Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 42. Canada Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 43. Mexico Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 44. Mexico Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 45. APAC Influenza Vaccine Consumption Market Share by Countries in 2019 Figure 46. APAC Influenza Vaccine Value Market Share by Regions in 2019 Figure 47. APAC Influenza Vaccine Consumption Market Share by Type in 2019 Figure 48. APAC Influenza Vaccine Consumption Market Share by Application in 2019 Figure 49. China Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 50. China Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 51. Japan Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 52. Japan Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 53. Korea Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 54. Korea Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 55. Southeast Asia Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 56. Southeast Asia Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 57. India Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 58. India Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 59. Australia Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 60. Australia Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 61. Europe Influenza Vaccine Consumption Market Share by Countries in 2019 Figure 62. Europe Influenza Vaccine Value Market Share by Countries in 2019 Figure 63. Europe Influenza Vaccine Consumption Market Share by Type in 2019 Figure 64. Europe Influenza Vaccine Consumption Market Share by Application in 2019 Figure 65. Germany Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 66. Germany Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 67. France Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 68. France Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 69. UK Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 70. UK Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 71. Italy Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 72. Italy Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 73. Russia Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 74. Russia Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 75. Spain Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 76. Spain Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 77. Middle East & Africa Influenza Vaccine Consumption Market Share by Countries in 2019 Figure 78. Middle East & Africa Influenza Vaccine Value Market Share by Countries in 2019 Figure 79. Middle East & Africa Influenza Vaccine Consumption Market Share by Type in 2019 Figure 80. Middle East & Africa Influenza Vaccine Consumption Market Share by Application in 2019 Figure 81. Egypt Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 82. Egypt Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 83. South Africa Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 84. South Africa Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 85. Israel Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 86. Israel Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 87. Turkey Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 88. Turkey Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 89. GCC Countries Influenza Vaccine Consumption Growth 2015-2020 (K Doses) Figure 90. GCC Countries Influenza Vaccine Value Growth 2015-2020 ($ Millions) Figure 91. Global Influenza Vaccine Consumption Growth Rate Forecast (2021-2025) (K Doses) Figure 92. Global Influenza Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 93. Americas Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 94. Americas Influenza Vaccine Value 2021-2025 ($ Millions) Figure 95. APAC Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 96. APAC Influenza Vaccine Value 2021-2025 ($ Millions) Figure 97. Europe Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 98. Europe Influenza Vaccine Value 2021-2025 ($ Millions) Figure 99. Middle East & Africa Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 100. Middle East & Africa Influenza Vaccine Value 2021-2025 ($ Millions) Figure 101. United States Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 102. United States Influenza Vaccine Value 2021-2025 ($ Millions) Figure 103. Canada Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 104. Canada Influenza Vaccine Value 2021-2025 ($ Millions) Figure 105. Mexico Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 106. Mexico Influenza Vaccine Value 2021-2025 ($ Millions) Figure 107. Brazil Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 108. Brazil Influenza Vaccine Value 2021-2025 ($ Millions) Figure 109. China Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 110. China Influenza Vaccine Value 2021-2025 ($ Millions) Figure 111. Japan Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 112. Japan Influenza Vaccine Value 2021-2025 ($ Millions) Figure 113. Korea Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 114. Korea Influenza Vaccine Value 2021-2025 ($ Millions) Figure 115. Southeast Asia Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 116. Southeast Asia Influenza Vaccine Value 2021-2025 ($ Millions) Figure 117. India Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 118. India Influenza Vaccine Value 2021-2025 ($ Millions) Figure 119. Australia Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 120. Australia Influenza Vaccine Value 2021-2025 ($ Millions) Figure 121. Germany Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 122. Germany Influenza Vaccine Value 2021-2025 ($ Millions) Figure 123. France Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 124. France Influenza Vaccine Value 2021-2025 ($ Millions) Figure 125. UK Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 126. UK Influenza Vaccine Value 2021-2025 ($ Millions) Figure 127. Italy Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 128. Italy Influenza Vaccine Value 2021-2025 ($ Millions) Figure 129. Russia Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 130. Russia Influenza Vaccine Value 2021-2025 ($ Millions) Figure 131. Spain Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 132. Spain Influenza Vaccine Value 2021-2025 ($ Millions) Figure 133. Egypt Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 134. Egypt Influenza Vaccine Value 2021-2025 ($ Millions) Figure 135. South Africa Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 136. South Africa Influenza Vaccine Value 2021-2025 ($ Millions) Figure 137. Israel Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 138. Israel Influenza Vaccine Value 2021-2025 ($ Millions) Figure 139. Turkey Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 140. Turkey Influenza Vaccine Value 2021-2025 ($ Millions) Figure 141. GCC Countries Influenza Vaccine Consumption 2021-2025 (K Doses) Figure 142. GCC Countries Influenza Vaccine Value 2021-2025 ($ Millions) Figure 143. CSL Influenza Vaccine Market Share (2018-2020) Figure 144. GSK Influenza Vaccine Market Share (2018-2020) Figure 145. Mylan Influenza Vaccine Market Share (2018-2020) Figure 146. AstraZeneca Influenza Vaccine Market Share (2018-2020) Figure 147. Sanofi Pasteur Influenza Vaccine Market Share (2018-2020) Figure 148. Pfizer Influenza Vaccine Market Share (2018-2020) Figure 149. Johnson & Johnson Influenza Vaccine Market Share (2018-2020)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by LP Information Inc

Global Personal Watercraft Market Growth 2020-2025

According to this study, over the next five years the Personal Watercraft market will register a 6.2% CAGR in terms of revenue, the global market size will reach $ 2059.2 million by 2025, from $ 1617.4 million in 2019. In particular, this report pres...

Global Protocol Analyzer Market Growth 2020-2025

According to this study, over the next five years the Protocol Analyzer market will register a 1.3% CAGR in terms of revenue, the global market size will reach $ 1002.4 million by 2025, from $ 950.1 million in 2019. In particular, this report present...

Global Wake-Up Light Alarm Clock Market Growth 2020-2025

According to this study, over the next five years the Wake-Up Light Alarm Clock market will register a 14.0% CAGR in terms of revenue, the global market size will reach $ 211.6 million by 2025, from $ 125.3 million in 2019. In particular, this report...

Global HEPA Filters Market Growth 2020-2025

According to this study, over the next five years the HEPA Filters market will register a 4.5% CAGR in terms of revenue, the global market size will reach $ 2332.1 million by 2025, from $ 1958.5 million in 2019. In particular, this report presents th...

Global Quick Disconnect Fittings Market Growth 2020-2025

According to this study, over the next five years the Quick Disconnect Fittings market will register a 3.9% CAGR in terms of revenue, the global market size will reach $ 10590 million by 2025, from $ 9074 million in 2019. In particular, this report p...

New Pharmaceuticals and Healthcare Reports

Publisher: LP Information Inc